Litigation Details for Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)
✉ Email this page to a colleague
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-08-06 |
Court | District Court, D. Delaware | Date Terminated | 2023-03-29 |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | None | Referred To | |
Patents | 10,065,952 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc.
Details for Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-08-06 | 1 | Complaint | this Court for patent infringement of U.S. Patent Nos. 10,065,952 (“the ’952 patent”), 10,844,058 …action for patent infringement of U.S. Patent No. 10,993,941 (“the ’941 patent” or “the patent-in-suit”… (“the ’058 patent”), 10,851,103 (“the ’103 patent”), 10,851,104 (“the ’104 patent”), 10,857,137 … (“the ’137 patent”), 10,857,148 (“the ’148 patent”), 10,874,648 (“the ’648 patent”), 10,906,902 (“the…“the ’902 patent”), 10,906,903 (“the ’903 patent”), 10,912,771 (“the ’771 patent”), 10,919,892 (“the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |